+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Complera"

HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Complera is a combination antiretroviral medication used to treat HIV/AIDS. It is a fixed-dose combination of three drugs: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. Complera is used to treat HIV-1 infection in adults and adolescents aged 12 years and older who have not taken antiretroviral medications before. It is also used to replace a current antiretroviral regimen in adults and adolescents aged 12 years and older who are virologically suppressed on a stable antiretroviral regimen for at least six months. Complera is a part of the larger HIV/AIDS drug market, which includes a variety of antiretroviral medications used to treat HIV/AIDS. These medications are used to reduce the amount of HIV in the body, prevent the virus from replicating, and reduce the risk of HIV-related illnesses. Some companies in the Complera market include Gilead Sciences, Janssen Pharmaceuticals, and ViiV Healthcare. Show Less Read more